Some scientists hope to exploit the phenomenon to get around ethical concerns
surrounding embryonic stem cell research.
Not exact matches
Leading US
research institutions may stop studying several federally - fundable linkurl:
embryonic stem cell; https://www.the-scientist.com/blog/display/54749/ lines due to potential ethical problems
surrounding the creation of the lines.
The excitement
surrounding cellular reprogramming and the possibility of federal funding for human
embryonic stem cell (ESC)
research in the US could be overshadowing another promising therapeutic source of
stem cells: those derived via parthenogenesis, some researchers say.